NCT01404715View on ClinicalTrials.gov

Drug-drug Interaction Study With Metformin and Imatinib

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Healthy
Interventions
DRUG

Metformin

Subjects will be given an oral dose of 1000 mg of metformin followed by an oral dose of 850 mg for a grand total of 1850 mg in both study Arm 1 and study Arm 2.

DRUG

Imatinib

A single oral dose of 600 mg of imatinib

Trial Locations (1)

94143

Ucsf Ctsi Crc, San Francisco

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of General Medical Sciences (NIGMS)

NIH

lead

University of California, San Francisco

OTHER

NCT01404715 - Drug-drug Interaction Study With Metformin and Imatinib | Biotech Hunter | Biotech Hunter